Le Lézard
Classified in: Health
Subjects: MAV, WOM, CSR

Interview and Photo Opportunity at Finish Line: Novartis employees complete 600-km bike race today


DORVAL, QC, Sept. 26, 2017 /CNW/ - Come cheer on 54 Novartis employees as they cross the finish line today after a 3.5 day, 600-kilometer charitable bike race that raised funds for the Quebec Breast Cancer Foundation (QBCF). The company's annual Ride for Life kicked off in Toronto on September 23rd, making stops in Kingston and Ottawa before returning home to Montreal.

In Quebec, one out of nine women will develop breast cancer in the course of her lifetime and sadly, one out of 30 women will die from it.1

What:

Photo and interview opportunity:
  • Meet the riders at the finish line and speak to them about their experiences on this hard-fought journey

  • Learn more about the work that the QBCF is doing to help support women in Quebec living with and affected by breast cancer as well as Novartis' commitment to those people living with the advanced form of the disease

Who: 

Nathalie Tremblay, CEO, Quebec Breast Cancer Foundation

Karen Iseult-Ippersiel, Vice-President of Business Development and Strategy, Quebec Breast Cancer Foundation

Marie-Andrée Cyr, Ride for Life President, Oncology Business Unit, Novartis Pharmaceuticals Canada Inc.


Winselow Tucker, General Manager, Oncology Business Unit, Novartis Pharmaceuticals Canada Inc.



Where:

Tuesday, September 26th, 4:30 PM



When:

Ride for Life Cyclists Arrival Day Celebration & Closing Ceremony, Novartis Pharmaceuticals Canada Inc

385 Bouchard Blvd., Dorval, Quebec.

*As part of the closing ceremony at Novartis, a cheque representing this year's proceeds will be presented to the QBCF.

About Ride for Life
Ride for LifeTM is an initiative launched in 2005 by Novartis employees wanting to help raise awareness and funds to the breast cancer community. Since 2005, Novartis has raised over $1 million dollars for the Quebec Breast Cancer Foundation, making them one of the largest fundraising teams in Quebec. To contribute to this cause or to learn more, please visit www.rubanrose.org/fundraising/activities/2017-ride-for-life.

About Novartis Pharmaceuticals Canada
Novartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development and marketing of innovative products to improve the well-being of all Canadians. In 2016, the company invested $48.8 million in research and development in Canada. Located in Dorval, Quebec, Novartis Pharmaceuticals Canada Inc. employs approximately 750 people in Canada and is an affiliate of Novartis AG, which provides innovative healthcare solutions that address the evolving needs of patients and societies. For further information, please consult www.novartis.ca.

References
1 Canadian Breast Cancer Foundation. https://rubanrose.org/breast-cancer/understand/stats. Accessed on August 24, 2017.

SOURCE Novartis Pharmaceuticals Canada


These press releases may also interest you

at 19:29
Suffolk DBT Expands to Meet the Growing Need for Self-Harm, Suicidal Thoughts, and Depression Therapy.
Suffolk DBT is proud to announce the completion of their initial expansion to accommodate the growing need for DBT therapy...

at 18:24
Notice - NOVA TECH LTD and CYNTHIA PETION, File No. 2023-20
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated Announces Increased First Quarter Dividend
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
Global Urine Output Monitoring Systems Market is Projected to Grow at a CAGR of ~5% by 2030 | DelveInsight
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video Partners With SONIFI Health To Deliver Advanced Telehealth Solutions In Hospital Rooms
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...

More news about Health...


News published on and distributed by: